Full quote from transcript: "I would rather think that a synergy could be with other compounds targeting other pathways, like if Adu will get approved, we believe it will be synergistic to ANAVEX 2-73 because it is a different pathway. But also we have seen that ANAVEX 2-73 has been shown preclinically to prevent the disease. So it's not only the treatment which is the goal and that's what we're now finding out with our ongoing Phase 3 study in Alzheimer's disease.
But also thinking ahead strategically that one day of ANAVEX 2-73 could be used as a daily mini-aspirin potentially to avoid being -- coming in near to be in a situation where you get affected by or afflicted by such a horrible disease like Alzheimer's disease."